Publication | Closed Access

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Gastrointestinal OncologyMedicinePharmacologyColorectal CancerPathologyProfiling Utilization RegistryMetastatic Colorectal CancerTargeted AgentCancer TreatmentOncologyRadiation OncologyMolecular Oncology